IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways

Oncogene

Volumn 33, Issue 26, 2014, Pages 3374-3382

  Zhang, Z ^a   Yang, M ^a   Chen, R ^a   Su, W ^b   Li, P ^a   Chen, S ^a   Chen, Z ^a   Chen, A ^a   Li, S ^a   Hu, C ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Maternal and Child Health Care Hospital   (China)

Author keywords

breast cancer; EMT; IBP; invasion; migration

Indexed keywords

CYTOKERATIN 18; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBRONECTIN; INTERFERON REGULATORY FACTOR 4 BINDING PROTEIN; METALLOPROTEINASE; NERVE CELL ADHESION MOLECULE; NUCLEIC ACID BINDING PROTEIN; PROTEIN CDC42; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; EGFR PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; RAC1 PROTEIN, HUMAN; REPRESSOR PROTEIN; RHOA PROTEIN, HUMAN; SMALL INTERFERING RNA; SNAIL FAMILY TRANSCRIPTION FACTORS; ZEB1 PROTEIN, HUMAN; ZEB2 PROTEIN, HUMAN;

ACTIN FILAMENT; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; FEMALE; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION;

GASTROPODA;

BREAST NEOPLASMS; CADHERINS; CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; INTERFERON REGULATORY FACTORS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RAC1 GTP-BINDING PROTEIN; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRESSOR PROTEINS; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84903574109     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.337     Document Type: Article

References (29)

1. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15-33.
2. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
3. Hotfilder M, Baxendale S, Cross MA, Sablitzky F. Def-2, -3, -6 and -8, novel mouse genes differentially expressed in the haemopoietic system. Br J Haematol 1999; 106: 335-344.
4. Canonigo-Balancio AJ, Fos C, Prod'homme T, Becart S, Altman A. SLAT/Def6 plays a critical role in the development of Th17 cell-mediated experimental autoimmune encephalomyelitis. J Immunol 2009; 183: 7259-7267.
5. Mavrakis KJ, McKinlay KJ, Jones P, Sablitzky F. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA. Exp Cell Res 2004; 294: 335-344.
6. Tanaka Y, Bi K, Kitamura R, Hong S, Altman Y, Matsumoto A et al. SWAP-70-like adapter of T cells, an adapter protein that regulates early TCR-initiated signaling in Th2 lineage cells. Immunity 2003; 18: 403-414.
7. Gupta S, Lee A, Hu C, Fanzo J, Goldberg I, Cattoretti G et al. Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system. Hum Immunol 2003; 64: 389-401.
8. Becart S, Balancio AJ, Charvet C, Feau S, Sedwick CE, Altman A. Tyrosinephosphorylation- dependent translocation of the SLAT protein to the immunological synapse is required for NFAT transcription factor activation. Immunity 2008; 29: 704-719.
9. Becart S, Charvet C, Canonigo Balancio AJ, De Trez C, Tanaka Y, Duan W et al. SLAT regulates Th1 and Th2 inflammatory responses by controlling Ca2+/NFAT signaling. J Clin Invest 2007; 117: 2164-2175.
10. Fanzo JC, Yang W, Jang SY, Gupta S, Chen Q, Siddiq A et al. Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity. J Clin Invest 2006; 116: 703-714.
11. Oka T, Ihara S, Fukui Y. Cooperation of DEF6 with activated Rac in regulating cell morphology. J Biol Chem 2007; 282: 2011-2018.
12. Samson T, Will C, Knoblauch A, Sharek L, von der Mark K, Burridge K et al. Def-6, a guanine nucleotide exchange factor for Rac1, interacts with the skeletal muscle integrin chain alpha7A and influences myoblast differentiation. J Biol Chem 2007; 282: 15730-15742.
13. Hey F, Czyzewicz N, Jones P, Sablitzky F. DEF6, a novel substrate for the Tec kinase ITK, contains a glutamine-rich aggregation-prone region and forms cytoplasmic granules that co-localize with P-bodies. J Biol Chem 2012; 287: 31073-31084.
14. Zhang Z, Wang Q, Li P, Zhou Y, Li S, Yi W et al. Overexpression of the Interferon regulatory factor 4-binding protein in human colorectal cancer and its clinical significance. Cancer Epidemiol 2009; 33: 130-136.
15. Li P, Zhang Z, Wang Q, Li S, Zhang Y, Bian X et al. The ectopic expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells. Int Immunopharmacol 2009; 9: 1002-1009.
16. Yang M, Yuan F, Li P, Chen Z, Chen A, Li S et al. Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatin-induced apoptosis of breast cancer cells. Mol Cancer 2012; 11: 54.
17. Byles V, Zhu L, Lovaas JD, Chmilewski LK, Wang J, Faller DV et al. SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene 2012; 31: 4619-4629.
18. Hardy KM, Booth BW, Hendrix MJ, Salomon DS, Strizzi L. ErbB/EGF signaling and EMT in mammary development and breast cancer. J Mammary Gland Biol Neoplasia 2010; 15: 191-199.
19. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 2005; 24: 7443-7454.
20. Mimeault M, Batra SK. Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Ann Oncol 2007; 18: 1605-1619.
21. Barr S, Thomson S, Buck E, Russo S, Petti F, Sujka-Kwok I et al. Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal- like transitions. Clin Exp Metastasis 2008; 25: 685-693.
22. Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 2007; 67: 9066-9076.
23. Hugo HJ, Wafai R, Blick T, Thompson EW, Newgreen DF. Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulation. BMC Cancer 2009; 9: 235.
24. Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008; 27: 6958-6969.
25. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279: 509-514.
26. Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett 2008; 582: 2093-2101.
27. Bendris N, Arsic N, Lemmers B, Blanchard JM. Cyclin A2, Rho GTPases and EMT. Small Gtpases 2012; 3: 225-228.
28. Jian CX, Yang MZ, Li P, Xiong J, Zhang ZJ, Li CJ et al. Ectopically expressed IBP promotes cell proliferation in oral squamous cell carcinoma. Cancer Invest 2012; 30: 748-756.
29. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993; 85: 200-206.